SCHEMBL9078885

SCHEMBL9078885

Cc1nc2c(=O)ccccc2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 6/20 0.53
▸ ALDH1A1 P00352 2/20 0.47
▸ DHODH Q02127 1/20 0.43
▸ TNKS2 Q9H2K2 1/20 0.43
▸ CYP1A2 P05177 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ DRD2 P14416 1/20 0.40
▸ DRD4 P21917 1/20 0.40
▸ DRD3 P35462 1/20 0.40
▸ GAA P10253 2/20 0.40
▸ BRD4 O60885 1/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2508265 0.76 PARP1 (0.44) PARP1ALDH1A1KDM4EGAASMN1; SMN2
SCHEMBL2509341 0.76 HSD17B10 (0.53) PARP1ALDH1A1KDM4EHPGDPOLB
SCHEMBL13594653 0.75 ADRB2 (0.52) PARP1ALDH1A1DHODHCYP1A2KDM4E
SCHEMBL20936149 0.75 PARP1 (0.56) PARP1ALDH1A1CYP1A2KDM4ECYP2D6
SCHEMBL353891 0.75 PARP1 (0.56) PARP1GAA
Bromide SCHEMBL5318091 0.73 PARP1 (0.55) PARP1GAA
SCHEMBL5788740 0.73 PARP1 (0.54) PARP1ALDH1A1DHODHCYP1A2KDM4E
SCHEMBL4366276 0.73 KMT2A (0.44) PARP1ALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL3884588 0.72 PARP1 (0.59) PARP1ALDH1A1DHODHCYP1A2KDM4E
SCHEMBL1013125 0.72 PARP1 (0.59) PARP1ALDH1A1DHODHCYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016109706-A1 FUSED POLYCYCLIC 2-PYRIDINONE ANTIBACTERIAL COMPOUNDS PTC THERAPEUTICS, INC. (US) 2016-07-07 — — WO disclosed
US-5527815-A TREATMENT OF HYPERTENSION, CONGESTIVE HEART FAILURE, AND HIGH INTRAOCULAR PRESSURE KOTOBUKI SEIYAKU CO., LTD. (JP) 1996-06-18 — — US disclosed
Send feedback